| Ilomastat | IC50 | 1.0 [1], 5.1 [2], 5.2 [3], 13.0 [4] |
| Ilomastat | Ki | 0.52 [1], 3.8 [2] |
| 2-[2-[4-(4-Methoxyphenyl)phenyl]sulfonylphenyl]ethanoic acid | IC50 | 140.0 [1], 150.0 [2], 170.0 [3] |
| Ageladine A | IC50 | 3660.0 [1] |
| (4S)-5-Amino-4-[[(2S)-2-[[(2S)-2-[[(4-bromophenyl)-hydroxyphosphoryl]methyl]-3-[3-[4-(3-chlorophenyl)phenyl]-1,2-oxazol-5-yl]propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoic acid | Ki | 0.19 [1], 0.24 [2], 0.26 [3] |
| Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate | IC50 | 30000.0 [1], 100000.0 [2] |
| N-Hydroxy-2-{2-[4-(4-methoxy-phenoxy)benzenesulfonyl]-phenyl}acetamide | IC50 | 0.2 [1], 0.85 [2], 0.89 [3] |
| cis-2-Aminocyclohexylcarbamoylphosphonic acid | IC50 | 100000.0 [1] |
| Mmp inhibitor II | Ki | 0.61 [1], 1.9 [2] |
| 4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2h)-Yl]methyl}benzoic Acid | IC50 | 30000.0 [1], 100000.0 [2] |
| (3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoyl]amino]oxane-3-carboxamide | IC50 | 8000.0 [1] |
| N-({4'-[(1-Benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-YL}sulfonyl)-L-valine | IC50 | 14.0 [1] |
| (2S)-2-[[8-(Methoxycarbonylamino)dibenzofuran-3-yl]sulfonylamino]-3-methylbutanoic acid | IC50 | 2.0 [1] |
| (Biphenyl-4-sulfonylamino)-acetic acid | IC50 | 290.0 [1] |
| (Biphenyl-4-sulfonylamino)-acetic acid | Ki | 18000.0 [1] |
| (4-Benzylphenyl)methyl-[2-[[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]carbamoyl]-4-phenylbutyl]phosphinic acid | IC50 | 8.13 [1], 8.2 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-fluoro-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 346.74 [1], 350.0 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-bromo-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 338.84 [1], 340.0 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-chloro-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 520.0 [1], 524.81 [2] |
| (8S,11R,12S)-12-N-Hydroxy-8-N-(2-morpholin-4-yl-2-oxoethyl)-2,10-dioxo-11-[[4-[2-(trifluoromethyl)phenyl]phenyl]methyl]-1-oxa-3,9-diazacyclopentadecane-8,12-dicarboxamide | Ki | 2000.0 [1] |
| 2-Benzenesulfonylamino-N-[5-(4-trifluoromethyl-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 300.0 [1], 302.0 [2] |
| 2-Benzenesulfonylamino-N-(5-p-tolyl-6H-[1,3,4]thiadiazin-2-yl)-propionamide | Ki | 89.13 [1], 90.0 [2] |
| (2S)-2-(Benzenesulfonamido)-N-[5-(4-fluorophenyl)-6H-1,3,4-thiadiazin-2-yl]propanamide | Ki | 280.0 [1], 281.84 [2] |
| (2S)-2-(Benzenesulfonamido)-N-[5-(4-nitrophenyl)-6H-1,3,4-thiadiazin-2-yl]propanamide | Ki | 280.0 [1], 281.84 [2] |
| 4-[(2-Methylquinolin-4-yl)methoxy]-N-[[5-(4-methylsulfonylpiperazin-1-yl)-2,4,6-trioxo-1,3-diazinan-5-yl]methyl]benzamide | Ki | 1020.0 [1] |
| N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)-2-benzenesulfonylamino-propionamide | Ki | 410.0 [1] |
| (2S)-2-(Benzenesulfonamido)-N-[5-(4-bromophenyl)-6H-1,3,4-thiadiazin-2-yl]propanamide | Ki | 436.52 [1], 440.0 [2] |
| (2S)-2-(Benzenesulfonamido)-N-[5-(4-cyanophenyl)-6H-1,3,4-thiadiazin-2-yl]propanamide | Ki | 370.0 [1], 371.54 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-methoxy-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 338.84 [1], 340.0 [2] |
| (2R)-2-(Benzenesulfonamido)-N-[5-(4-chlorophenyl)-6H-1,3,4-thiadiazin-2-yl]propanamide | Ki | 320.0 [1], 323.59 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-chloro-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-3-methyl-butyramide | Ki | 380.0 [1], 380.19 [2] |
| (2R)-2-(Benzenesulfonamido)-N-[5-(4-chlorophenyl)-6H-1,3,4-thiadiazin-2-yl]-3-methylbutanamide | Ki | 346.74 [1], 350.0 [2] |
| (2S)-2-(Benzenesulfonamido)-N-[5-(4-methylphenyl)-6H-1,3,4-thiadiazin-2-yl]propanamide | Ki | 109.65 [1], 110.0 [2] |
| 4-((2-Methylquinolin-4-yl)methoxy)-N-(2-(2-oxo-2,3-dihydro-1H-imidazole-5-carbonyl)phenyl)benzamide | Ki | 6023.0 [1] |
| 5-[3-Fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]-N-[(2S)-3-methyl-1-(methylamino)-1-oxobutan-2-yl]furan-2-carboxamide | IC50 | 1800.0 [1] |
| 1'-Benzyl-5-(4-methoxyphenyl)-5'-methylspiro[3H-1,3,4-thiadiazole-2,3'-indole]-2'-one | IC50 | 22000.0 [1] |
| (3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]methyl]benzoyl]amino]oxane-3-carboxamide | Ki | 6023.0 [1] |
| (2S)-2-[[8-[(4-Fluorophenoxy)carbonylamino]dibenzofuran-3-yl]sulfonylamino]-3-methylbutanoic acid | IC50 | 6.2 [1], 8.1 [2] |
| 5-(2-Amino-2-oxoethyl)-4-oxo-N-[(3-oxo-4H-1,4-benzoxazin-6-yl)methyl]-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidine-2-carboxamide | IC50 | 2500.0 [1], 10000.0 [2] |
| (2S)-2-[[8-(Ethoxycarbonylamino)dibenzofuran-3-yl]sulfonylamino]-3-methylbutanoic acid | IC50 | 5.0 [1] |
| (2S)-2-[[7-(Methoxycarbonylamino)dibenzofuran-3-yl]sulfonylamino]-3-methylbutanoic acid | IC50 | 12.0 [1], 14.0 [2] |
| (2R)-2-(Dibenzofuran-2-ylsulfonylamino)-3-methylbutanoic acid | IC50 | 38.0 [1] |
| (2S)-2-(Dibenzofuran-2-ylsulfonylamino)-3-methylbutanoic acid | IC50 | 600.0 [1] |
| L-Valine, N-((8-(2-oxo-3-oxazolidinyl)-3-dibenzofuranyl)sulfonyl)- | IC50 | 1.4 [1], 2.0 [2] |
| Benzyl-[2-((S)-2,2-dimethyl-1-methylcarbamoyl-propylcarbamoyl)-4-phenyl-butyl]-phosphinic acid | IC50 | 93.0 [1], 93.33 [2] |
| (4-Benzylphenyl)methyl-[4-(4-chlorophenyl)-2-[[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]carbamoyl]butyl]phosphinic acid | IC50 | 1.7 [1] |
| [2-[[(2S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl]carbamoyl]-4-phenylbutyl]-[[4-[(2-methoxyphenyl)methyl]phenyl]methyl]phosphinic acid | IC50 | 3.98 [1], 4.0 [2] |
| 4-(4-Bromo-1H-pyrrol-2-yl)-1H-imidazo[4,5-c]pyridin-2-amine | IC50 | 100000.0 [1] |
| 4-(5-Bromo-1H-pyrrol-2-yl)-1H-imidazo[4,5-c]pyridin-2-amine | IC50 | 100000.0 [1] |
| N-Hydroxy-2-[2-[4-(4-methoxyphenyl)phenyl]sulfonylphenyl]acetamide | IC50 | 4.8 [1] |
| (6S,7S)-N-Hydroxy-5-methyl-6-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbonyl]-5-azaspiro[2.5]octane-7-carboxamide | IC50 | 564.0 [1] |
| (6S,7S)-N-Hydroxy-5-methyl-6-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbonyl]-5-azaspiro[2.5]octane-7-carboxamide | Ki | 29.5 [1] |
| N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-[2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]acetamide | Ki | 14.3 [1] |
| [4-(4-Chlorophenyl)-2-[[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]carbamoyl]butyl]-[[4-[(2-methoxyphenyl)methyl]phenyl]methyl]phosphinic acid | IC50 | 5.0 [1], 5.01 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-cyano-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 360.0 [1], 363.08 [2] |
| 4-(4-Methoxyphenyl)-N-(2-morpholin-4-ylethyl)thiophene-2-carboxamide | IC50 | 230.0 [1], 13000.0 [2] |
| (2R)-N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-2-[[4-(trifluoromethyl)phenyl]methyl]butanamide | IC50 | 26.0 [1] |
| N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-2,2-dimethyl-3-[4-(trifluoromethyl)phenyl]propanamide | IC50 | 71.0 [1] |
| (2S)-2-Cyclopropyl-N-[[(4R)-4-cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]propanamide | IC50 | 268.0 [1], 270.0 [2] |
| (2S)-N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-3-methyl-2-[[4-(trifluoromethyl)phenyl]methyl]butanamide | IC50 | 3365.0 [1], 3400.0 [2] |
| (2R)-N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-2-methyl-3-[4-(trifluoromethyl)phenyl]propanamide | IC50 | 9.0 [1] |
| 5-[Benzyl-(4-methoxyphenyl)sulfonylamino]-2-(diethylaminomethyl)-N-hydroxy-4-methylbenzamide | Ki | 3.53 [1], 30.0 [2] |
| Quercetin | IC50 | 10230.0 [1] |
| Luteolin | IC50 | 980.0 [1] |
| Clodronic Acid | IC50 | 121000.0 [1] |
| Marimastat | IC50 | 10000.0 [1] |
| Dihydroquercetin | IC50 | 5750.0 [1] |
| Isoacteoside | IC50 | 8220.0 [1] |
| 5-Phenylhydantoin | IC50 | 290.0 [1] |
| N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid | Ki | 4.3 [1] |
| Unii-Q56UE7E40Y | IC50 | 17.0 [1] |
| N-Hydroxy-N~2~-[(4-Methoxyphenyl)sulfonyl]glycinamide | Ki | 20.0 [1] |
| (R)-N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamide | IC50 | 0.2 [1] |
| Methyl rosmarinate | IC50 | 2750.0 [1] |
| 4-(4-Methylphenoxy)-N-(4-pyridinylmethyl)benzenecarboxamide | IC50 | 100000.0 [1] |
| Grassystatin A | IC50 | 5000.0 [1] |
| 2-(Biphenyl-4-ylsulfonamido)-N-hydroxyacetamide | Ki | 2.0 [1] |
| 2-(Benzenesulfonamido)-N-hydroxyacetamide | Ki | 62.0 [1] |
| 6-(2-Methylthiazol-4-yl)-3,4-dihydroquinolin-2(1H)-one | IC50 | 5000000.0 [1] |
| 2H-Pyran-4-carboxamide, 4-(((4-(4-fluorophenoxy)phenyl)sulfonyl)amino)tetrahydro-N-hydroxy- | IC50 | 0.24 [1] |
| (2R,3R)-1-[4-[(2-Chloro-4-fluorophenyl)methoxy]phenyl]sulfonyl-N,3-dihydroxy-3-methylpiperidine-2-carboxamide | IC50 | 1.0 [1] |
| Dimethyl Lithospermate | IC50 | 670.0 [1] |
| 5-Methoxybenzimidazole | IC50 | 2000000.0 [1] |
| (2R)-2-(4-Fluoro-3,5-dimethylanilino)-6-[(4-fluorophenyl)methylamino]-N-hydroxyhexanamide | Ki | 50000.0 [1] |
| 8-Chloro-2-methyl-2,4-dihydrothiochromeno[4,3-c]pyrazole | IC50 | 1000000.0 [1] |
| N,6-Dihydroxy-2-(4-nitrophenylsulfonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide | IC50 | 59.0 [1] |
| 3-Phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-YL]carbonyl}amino)propanoic acid | IC50 | 14.0 [1] |
| (10R)-19-Cyclohexyl-10-[2-(dimethylamino)ethyl-methylamino]-8-oxa-12-azatetracyclo[10.7.0.02,7.013,18]nonadeca-1(19),2,4,6,13(18),14,16-heptaene-15-carboxylic acid | IC50 | 8300.0 [1] |
| (2R)-N-Hydroxy-2-methyl-2-methylsulfonyl-4-(4-phenylphenyl)butanamide | Ki | 1350.0 [1] |
| 2-Benzenesulfonylamino-N-[5-(5-chloro-thiophen-2-yl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 240.0 [1] |
| N-((4-Methyl-2,5-dioxoimidazolidin-4-yl)methyl)-4-((2-methylquinolin-4-yl)methoxy)benzamide | Ki | 5025.0 [1] |
| (3R,4R)-N-Hydroxy-4-[[4-[(2-methylquinolin-4-yl)methoxy]benzoyl]amino]oxane-3-carboxamide | Ki | 100.0 [1] |
| 6-(Benzyloxy)-N-hydroxy-2-(4-methoxyphenylsulfonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide | IC50 | 57.0 [1] |
| 2-[[(2S)-2,3-Dihydroxypropyl]-(4-methoxyphenyl)sulfonylamino]-N-hydroxyacetamide | Ki | 8.0 [1] |
| (3S,4S)-N-Hydroxy-4-[[4-[(2-methylquinolin-4-yl)methoxy]benzoyl]amino]-1-prop-2-ynylpyrrolidine-3-carboxamide | Ki | 12.0 [1] |
| (1S)-4-Methyl-1-[[5-[(3-oxo-4H-1,4-benzoxazin-6-yl)methylcarbamoyl]pyrazolo[1,5-a]pyrimidine-7-carbonyl]amino]-2,3-dihydro-1H-indene-5-carboxylic acid | IC50 | 655.0 [1] |
| 4-Oxo-N-[[3-[4-[(5-oxo-1,4-dihydro-1,2,4-triazol-3-yl)methylsulfonylmethyl]phenyl]phenyl]methyl]-3H-quinazoline-2-carboxamide | IC50 | 9500.0 [1] |
| (2S)-2-[(4-Fluoro-3,5-dimethylphenyl)methyl]-6-[(4-fluorophenyl)methylamino]-N-hydroxyhexanamide | Ki | 50000.0 [1] |
| (2R)-N,3-Dihydroxy-2-[(4-methoxyphenyl)sulfonylamino]propanamide | Ki | 6.0 [1] |
| 2-[(4-Fluorophenyl)sulfonyl-(2-hydroxyethyl)amino]-N-hydroxyacetamide | Ki | 40.0 [1] |